Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- solid plates metabolites EIAs enzyme immunoassays kits measures ELISAs 13,14-dh-15-k-PGF2.alpha. 13,14-dihydro-15-keto-PGF2.alpha. 13,14-dh-15-k-PGF2alpha 13,14-dihydro-15-keto-PGF2alpha 13,14-dh-15-k-prostaglandins 13,14-dihydro-15-keto-prostaglandins prostaglandins assays
- Product Overview:
Prostaglandin F2? (PGF2?) is one of the five primary prostaglandins derived enzymatically directly from the endoperoxide PGH2. PGF2? was initially discovered in seminal fluid, and to date the majority of the functional roles ascribed to it relate to fertility, pregnancy, and parturition. PGF2? is a potent luteolytic agent and is used to induce ovulation in domestic livestock. It is also a potent uterine stimulant, and is part of the cascade of myometrial stimulants which induce and sustain labor. PGF2? is rapidly metabolized to 13,14-dihydro-15-keto PGF2? in vivo, by the enzymes 15-hydroxy prostaglandin dehydrogenase and ?13-reductucase.{310,1157,5442,387} Measurement of 13,14-dihydro-15-keto PGF2? in plasma can be used as a marker of the in vivo production of PGF2?.{878,1463} The Cayman Chemical 13,14-dihydro-15-keto PGF2? Enzyme Immunoassay is a competitive assay that provides measurements of 13,14-dihydro-15-keto PGF2? within the range of 2.3-5,000 pg/ml, typically with a detection limit (80% B/B0) of approximately 15 pg/ml. Although the tracer and antiserum for this assay have been sold separately for many years, the reagents are now combined with an accurate standard and packaged together in a convenient assay kit. The assay has been validated for the measurement of 13,14-dihydro-15-keto PGF2? in plasma, a common matrix for measurement of this PGF2? metabolite.{878}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.